Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management
- PMID: 27104173
- PMCID: PMC4835564
- DOI: 10.6065/apem.2016.21.1.7
Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management
Abstract
Sitosterolemia is an autosomal recessive disorder characterized by increased plant sterol levels, xanthomas, and accelerated atherosclerosis. Although it was originally reported in patients with normolipemic xanthomas, severe hypercholesterolemia have been reported in patients with sitosterolemia, especially in children. Sitosterolemia is caused by increased intestinal absorption and decreased biliary excretion of sterols resulting from biallelic mutations in either ABCG5 or ABCG8, which encode the sterol efflux transporter ABCG5 and ABCG8. Patients with sitosterolemia show extreme phenotypic heterogeneity, ranging from almost asymptomatic individuals to those with severe hypercholesterolemia leading to accelerated atherosclerosis and premature cardiac death. Hematologic manifestations include hemolytic anemia with stomatocytosis, macrothrombocytopenia, splenomegaly, and abnormal bleeding. The mainstay of therapy includes dietary restriction of both cholesterol and plant sterols and the sterol absorption inhibitor, ezetimibe. Foods rich in plant sterols include vegetable oils, wheat germs, nuts, seeds, avocado, shortening, margarine and chocolate. Hypercholesterolemia in patients with sitosterolemia is dramatically responsive to low cholesterol diet and bile acid sequestrants. Plant sterol assay should be performed in patients with normocholesterolemic xanthomas, hypercholesterolemia with unexpectedly good response to dietary modifications or to cholesterol absorption inhibitors, or hypercholesterolemia with poor response to statins, or those with unexplained hemolytic anemia and macrothrombocytopenia. Because prognosis can be improved by proper management, it is important to find these patients out and diagnose correctly. This review article aimed to summarize recent publications on sitosterolemia, and to suggest clinical indications for plant sterol assay.
Keywords: Hypercholesterolemia; Phytosterolemia; Plant sterol; Sitosterolemia.
Conflict of interest statement
Similar articles
-
[Sitosterolemia (phytosterolemia)].Internist (Berl). 2019 Aug;60(8):871-877. doi: 10.1007/s00108-019-0635-2. Internist (Berl). 2019. PMID: 31254003 Review. German.
-
Sitosterolemia presenting with severe hypercholesterolemia and intertriginous xanthomas in a breastfed infant: case report and brief review.J Clin Endocrinol Metab. 2014 May;99(5):1512-8. doi: 10.1210/jc.2013-3274. Epub 2014 Jan 1. J Clin Endocrinol Metab. 2014. PMID: 24423340 Review.
-
Update on Sitosterolemia and Atherosclerosis.Curr Atheroscler Rep. 2023 May;25(5):181-187. doi: 10.1007/s11883-023-01092-4. Epub 2023 Mar 10. Curr Atheroscler Rep. 2023. PMID: 36897412 Review.
-
Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia.Am J Hematol. 2014 Mar;89(3):320-4. doi: 10.1002/ajh.23619. Am J Hematol. 2014. PMID: 24166850
-
A teenager boy with a novel variant of Sitosterolemia presented with pancytopenia.Clin Chim Acta. 2022 Apr 1;529:61-66. doi: 10.1016/j.cca.2022.02.001. Epub 2022 Feb 12. Clin Chim Acta. 2022. PMID: 35167844
Cited by
-
ABCG5/G8: a structural view to pathophysiology of the hepatobiliary cholesterol secretion.Biochem Soc Trans. 2019 Oct 31;47(5):1259-1268. doi: 10.1042/BST20190130. Biochem Soc Trans. 2019. PMID: 31654053 Free PMC article. Review.
-
Seventeen years of misdiagnosis in rare dyslipidaemia: a case report of sitosterolaemia in a young female.Eur Heart J Case Rep. 2021 May 19;5(5):ytab188. doi: 10.1093/ehjcr/ytab188. eCollection 2021 May. Eur Heart J Case Rep. 2021. PMID: 34268478 Free PMC article.
-
Platelet proteomic profiling in sitosterolemia suggests thrombocytopenia is driven by lipid disorder and not platelet aberrations.Blood Adv. 2024 May 28;8(10):2466-2477. doi: 10.1182/bloodadvances.2023012018. Blood Adv. 2024. PMID: 38513134 Free PMC article.
-
Sterols in Inflammatory Diseases: Implications and Clinical Utility.Adv Exp Med Biol. 2024;1440:261-275. doi: 10.1007/978-3-031-43883-7_13. Adv Exp Med Biol. 2024. PMID: 38036884 Review.
-
Remediation of ABCG5-Linked Macrothrombocytopenia With Ezetimibe Therapy.Front Genet. 2021 Nov 22;12:769699. doi: 10.3389/fgene.2021.769699. eCollection 2021. Front Genet. 2021. PMID: 34880906 Free PMC article.
References
-
- Salen G, Shefer S, Nguyen L, Ness GC, Tint GS, Shore V. Sitosterolemia. J Lipid Res. 1992;33:945–955. - PubMed
-
- Merkens LS, Myrie SB, Steiner RD, Mymin D. Sitosterolemia. GeneReviews [Internet] Seattle (WA): University of Washington; 2016. [updated 2013 Apr 4]. [cited 2016 Feb 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK131810/
-
- Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290:1771–1775. - PubMed
-
- Patel SB. Recent advances in understanding the STSL locus and ABCG5/ABCG8 biology. Curr Opin Lipidol. 2014;25:169–175. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources